Khamisy-Farah Rola, Farah Raymond, Atwan Hisham, Shehadeh Rabie, Shannan Inshirah Sgayer, Topchi Corinne, Moallem Yara, Hijazi Basem, Alshahrani Najim Z, Woldegerima Woldegebriel Assefa, Bragazzi Nicola Luigi
Clalit Health Services, Akko 13100, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 13100, Israel.
Healthcare (Basel). 2025 Apr 1;13(7):790. doi: 10.3390/healthcare13070790.
Mpox, a zoonotic viral disease, has recently emerged as a significant global public health challenge. Historically confined to endemic regions in West and Central Africa, recent outbreaks in non-endemic areas have highlighted the critical role of healthcare professionals (HCPs) in disease management and prevention. This cross-sectional study surveyed 709 Israeli HCPs, with a mean age of 40.6 ± 9.4 years, to evaluate their knowledge, perceptions, and attitudes toward mpox and identify gaps to inform educational and public health strategies. Findings revealed that only 38.9% of respondents demonstrated good knowledge about mpox, while 61.1% exhibited poor knowledge. Misconceptions were prevalent: 37.9% identified paracetamol as a management option, with only 31.0% recognizing the need for antivirals. Notably, 67.1% correctly identified mpox as a viral disease, yet only 47.2% were aware that lymphadenopathy is a distinguishing symptom. Multivariable analysis identified several predictors of good knowledge, including marital status, being a medical doctor (versus an allied health professional), work seniority, and previous exposure to mpox-related information. Attitudes varied, with 57.7% expressing confidence in the ability of global health authorities to control mpox, and 59.0% expressing confidence in the Israeli Ministry of Health. Interest in learning more about mpox and related topics was high, with 67.4% showing interest in the epidemiology of emerging diseases. Respondents with good knowledge consistently exhibited more positive attitudes and confidence in managing mpox-related challenges. These findings underscore the urgent need for targeted educational interventions to enhance HCPs' readiness and response capabilities. Strengthening professional training, incorporating emerging infectious diseases into curricula, and leveraging accurate media communication are critical steps toward improving preparedness for mpox and future outbreaks.
猴痘是一种人畜共患的病毒性疾病,最近已成为一项重大的全球公共卫生挑战。历史上,猴痘仅限于西非和中非的流行地区,但最近在非流行地区的爆发凸显了医疗保健专业人员(HCPs)在疾病管理和预防中的关键作用。这项横断面研究调查了709名以色列医疗保健专业人员,他们的平均年龄为40.6±9.4岁,以评估他们对猴痘的知识、认知和态度,并找出差距,为教育和公共卫生战略提供信息。研究结果显示,只有38.9%的受访者对猴痘有良好的了解,而61.1%的人知识匮乏。误解很普遍:37.9%的人将扑热息痛视为一种治疗选择,只有31.0%的人认识到需要使用抗病毒药物。值得注意的是,67.1%的人正确地将猴痘识别为病毒性疾病,但只有47.2%的人知道淋巴结病是一个显著症状。多变量分析确定了几个知识良好的预测因素,包括婚姻状况、是医生(相对于专职医疗人员)、工作资历以及以前接触过猴痘相关信息。态度各不相同,57.7%的人对全球卫生当局控制猴痘的能力表示有信心,59.0%的人对以色列卫生部表示有信心。对了解更多猴痘及相关主题的兴趣很高,67.4%的人对新发疾病的流行病学表现出兴趣。知识良好的受访者在应对猴痘相关挑战时始终表现出更积极的态度和信心。这些发现强调了有针对性的教育干预措施的迫切必要性,以提高医疗保健专业人员的准备程度和应对能力。加强专业培训、将新发传染病纳入课程以及利用准确的媒体传播是提高对猴痘和未来疫情的准备程度的关键步骤。